Cargando…
Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management
Background: Noninvasive prenatal screening (NIPS) utilization has grown dramatically and is increasingly offered to the general population by nongenetic specialists. Web-based technologies and telegenetic services offer potential solutions for efficient results delivery and genetic counseling. Intro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948005/ https://www.ncbi.nlm.nih.gov/pubmed/30807262 http://dx.doi.org/10.1089/tmj.2018.0253 |
_version_ | 1783485673115746304 |
---|---|
author | Arjunan, Aishwarya Ben-Shachar, Rotem Kostialik, Jamie Johansen Taber, Katherine Lazarin, Gabriel A. Denne, Elizabeth Muzzey, Dale Haverty, Carrie |
author_facet | Arjunan, Aishwarya Ben-Shachar, Rotem Kostialik, Jamie Johansen Taber, Katherine Lazarin, Gabriel A. Denne, Elizabeth Muzzey, Dale Haverty, Carrie |
author_sort | Arjunan, Aishwarya |
collection | PubMed |
description | Background: Noninvasive prenatal screening (NIPS) utilization has grown dramatically and is increasingly offered to the general population by nongenetic specialists. Web-based technologies and telegenetic services offer potential solutions for efficient results delivery and genetic counseling. Introduction: All major guidelines recommend patients with both negative and positive results be counseled. The main objective of this study was to quantify patient utilization, motivation for posttest counseling, and satisfaction of a technology platform designed for large-scale dissemination of NIPS results. Methods: The technology platform provided general education videos to patients, results delivery through a secure portal, and access to telegenetic counseling through phone. Automatic results delivery to patients was sent only to patients with screen-negative results. For patients with screen-positive results, either the ordering provider or a board-certified genetic counselor contacted the patient directly through phone to communicate the test results and provide counseling. Results: Over a 39-month period, 67,122 NIPS results were issued through the platform, and 4,673 patients elected genetic counseling consultations; 95.2% (n = 4,450) of consultations were for patients receiving negative results. More than 70% (n = 3,370) of consultations were on-demand rather than scheduled. A positive screen, advanced maternal age, family history, previous history of a pregnancy with a chromosomal abnormality, and other high-risk pregnancy were associated with the greatest odds of electing genetic counseling. By combining web education, automated notifications, and telegenetic counseling, we implemented a service that facilitates results disclosure for ordering providers. Discussion: This automated results delivery platform illustrates the use of technology in managing large-scale disclosure of NIPS results. Further studies should address effectiveness and satisfaction among patients and providers in greater detail. Conclusions: These data demonstrate the capability to deliver NIPS results, education, and counseling—congruent with professional society management guidelines—to a large population. |
format | Online Article Text |
id | pubmed-6948005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-69480052020-02-10 Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management Arjunan, Aishwarya Ben-Shachar, Rotem Kostialik, Jamie Johansen Taber, Katherine Lazarin, Gabriel A. Denne, Elizabeth Muzzey, Dale Haverty, Carrie Telemed J E Health Original Background: Noninvasive prenatal screening (NIPS) utilization has grown dramatically and is increasingly offered to the general population by nongenetic specialists. Web-based technologies and telegenetic services offer potential solutions for efficient results delivery and genetic counseling. Introduction: All major guidelines recommend patients with both negative and positive results be counseled. The main objective of this study was to quantify patient utilization, motivation for posttest counseling, and satisfaction of a technology platform designed for large-scale dissemination of NIPS results. Methods: The technology platform provided general education videos to patients, results delivery through a secure portal, and access to telegenetic counseling through phone. Automatic results delivery to patients was sent only to patients with screen-negative results. For patients with screen-positive results, either the ordering provider or a board-certified genetic counselor contacted the patient directly through phone to communicate the test results and provide counseling. Results: Over a 39-month period, 67,122 NIPS results were issued through the platform, and 4,673 patients elected genetic counseling consultations; 95.2% (n = 4,450) of consultations were for patients receiving negative results. More than 70% (n = 3,370) of consultations were on-demand rather than scheduled. A positive screen, advanced maternal age, family history, previous history of a pregnancy with a chromosomal abnormality, and other high-risk pregnancy were associated with the greatest odds of electing genetic counseling. By combining web education, automated notifications, and telegenetic counseling, we implemented a service that facilitates results disclosure for ordering providers. Discussion: This automated results delivery platform illustrates the use of technology in managing large-scale disclosure of NIPS results. Further studies should address effectiveness and satisfaction among patients and providers in greater detail. Conclusions: These data demonstrate the capability to deliver NIPS results, education, and counseling—congruent with professional society management guidelines—to a large population. Mary Ann Liebert, Inc., publishers 2020-01-01 2020-01-07 /pmc/articles/PMC6948005/ /pubmed/30807262 http://dx.doi.org/10.1089/tmj.2018.0253 Text en © Aishwarya Arjunan et al. 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are cited. |
spellingShingle | Original Arjunan, Aishwarya Ben-Shachar, Rotem Kostialik, Jamie Johansen Taber, Katherine Lazarin, Gabriel A. Denne, Elizabeth Muzzey, Dale Haverty, Carrie Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title | Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title_full | Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title_fullStr | Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title_full_unstemmed | Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title_short | Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management |
title_sort | technology-driven noninvasive prenatal screening results disclosure and management |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948005/ https://www.ncbi.nlm.nih.gov/pubmed/30807262 http://dx.doi.org/10.1089/tmj.2018.0253 |
work_keys_str_mv | AT arjunanaishwarya technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT benshacharrotem technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT kostialikjamie technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT johansentaberkatherine technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT lazaringabriela technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT denneelizabeth technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT muzzeydale technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement AT havertycarrie technologydrivennoninvasiveprenatalscreeningresultsdisclosureandmanagement |